Clinical trial
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
NCT00000556 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000556 |
|---|---|
| Title | Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arrhythmia, Atrial Fibrillation, Cardiovascular Diseases, Heart Diseases |
| Intervention type | Device, Drug, Procedure |
| Interventions | amiodarone, sotalol, propafenone, flecainide, quinidine, moricizine, disopyramide, procainamide, adrenergic beta antagonists, verapamil and 5 more |
| Start date | Mar 1, 1995 |
| Completion | Sep 1, 2002 |
| First posted | Oct 28, 1999 |
| Last update posted | Mar 25, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: